Chemical adjuvants for plasmid DNA vaccines

被引:123
作者
Greenland, John R. [1 ]
Letvin, Norman L. [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA
关键词
plasmid DNA; vaccine; adjuvant; polymer; BIODEGRADABLE ALGINATE MICROSPHERES; HUMORAL IMMUNE-RESPONSES; CYTOTOXIC T-LYMPHOCYTES; DIRECT GENE-TRANSFER; IN-VIVO; DENDRITIC CELLS; CATIONIC MICROPARTICLES; ANTIGEN PRESENTATION; PROTECTIVE IMMUNITY; PHASE-I;
D O I
10.1016/j.vaccine.2007.01.120
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmid DNA vaccines are a promising modality for immunization against a variety of human pathogens. Immunization via multiple routes with plasmid DNA can elicit potent cellular immune responses, and these immunogens can be administered repeatedly without inducing anti-vector immunity. Nonetheless, the immunogenicity of plasmid DNA vaccines has been limited by problems associated with delivery. A number of adjuvants have been designed to improve plasmid DNA immunogenicity, either by directly stimulating the immune system or by enhancing plasmid DNA expression. Chemical adjuvants for enhancing plasmid DNA expression include liposomes, polymers, and microparticles, all of which have shown promise for enhancing the expression and immunogenicity of plasmid DNA vaccines in animal models. Micro- and nanoparticles have not been shown to enhance immune responses to plasmid DNA vaccines. However, formulation of plasmid DNA with some non-particulate polymeric adjuvants has led to a statistically significant enhancement of immune responses. Further development of these technologies will significantly improve the utility of plasmid DNA vaccination. (C) 2007 Published by Elsevier Ltd.
引用
收藏
页码:3731 / 3741
页数:11
相关论文
共 141 条
[31]   Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice [J].
Dupuis, M ;
Denis-Mize, K ;
Woo, C ;
Goldbeck, C ;
Selby, MJ ;
Chen, MC ;
Otten, GR ;
Ulmer, JB ;
Donnelly, JJ ;
Ott, G ;
McDonald, DM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2850-2858
[32]   Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines [J].
Evans, RK ;
Zhu, DM ;
Casimiro, DR ;
Nawrocki, DK ;
Mach, H ;
Troutman, RD ;
Tang, AM ;
Wu, SL ;
Chin, S ;
Ahn, C ;
Isopi, LA ;
Williams, DM ;
Xu, Z ;
Shiver, JW ;
Volkin, DB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (07) :1924-1939
[33]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-RESTRICTED T-CELLS ARE REQUIRED FOR RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
GOLDSTEIN, MM ;
TRIEBOLD, KJ ;
KOLLER, B ;
BLOOM, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (24) :12013-12017
[34]   Rapid-response vaccines - does DNA offer a solution? [J].
Forde, GM .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1059-1062
[35]   Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Fu, K ;
Pack, DW ;
Klibanov, AM ;
Langer, R .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :100-106
[36]   Cationic polymethacrylates with covalently linked membrane destabilizing peptides as gene delivery vectors [J].
Funhoff, AM ;
Van Nostrum, CF ;
Lok, MC ;
Kruijtzer, JAW ;
Crommelin, DJA ;
Hennink, WE .
JOURNAL OF CONTROLLED RELEASE, 2005, 101 (1-3) :233-246
[37]   PEG shielded polymeric double-layered micelles for gene delivery [J].
Funhoff, AM ;
Monge, S ;
Teeuwen, R ;
Koning, GA ;
Schuurmans-Nieuwenbroek, NME ;
Crommelin, DJA ;
Haddleton, DM ;
Hennink, WE ;
van Nostrum, CF .
JOURNAL OF CONTROLLED RELEASE, 2005, 102 (03) :711-724
[38]   DNA VACCINES - PROTECTIVE IMMUNIZATIONS BY PARENTERAL, MUCOSAL, AND GENE-GUN INOCULATIONS [J].
FYNAN, EF ;
WEBSTER, RG ;
FULLER, DH ;
HAYNES, JR ;
SANTORO, JC ;
ROBINSON, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11478-11482
[39]  
Gao X, 1995, GENE THER, V2, P710
[40]   Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex [J].
Garzón, MR ;
Berraondo, P ;
Crettaz, J ;
Ochoa, L ;
Vera, M ;
Lasarte, JJ ;
Vales, A ;
Van Rooijen, N ;
Ruiz, J ;
Prieto, J ;
Zulueta, J ;
González-Aseguinolaza, G .
VACCINE, 2005, 23 (11) :1384-1392